EYEPOINT PHARMACEUTICALS INC shareholders Q2 2024

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 155 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 6.31 and the average weighting 0.1%.

EYEPOINT PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 1,551,521$13,498,2334.40%
Cormorant Asset Management, LP 8,325,000$72,427,5004.18%
ORACLE INVESTMENT MANAGEMENT INC 231,857$2,017,1561.88%
Finepoint Capital LP 707,404$6,154,4151.75%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,175,823$45,029,6601.65%
Octagon Capital Advisors LP 1,093,503$9,513,4761.50%
TCG Crossover Management, LLC 922,335$8,024,3150.84%
SUPERSTRING CAPITAL MANAGEMENT LP 37,838$329,1910.42%
Corton Capital Inc. 49,905$434,1740.23%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$870,0000.20%
MYDA Advisors LLC 100,000$870,0000.19%
Artia Global Partners LP 101,500$883,0500.17%
Perceptive Advisors 640,274$5,570,3840.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 877,790$7,636,7730.13%
PFM Health Sciences, LP 292,926$2,548,4560.13%
Laurion Capital Management LP 1,072,577$9,331,4200.11%
Caption Management, LLC 749,400$6,519,7800.10%
5AM Venture Management, LLC 50,000$435,0000.10%
Granahan Investment Management 201,332$1,751,5880.07%
ESSEX INVESTMENT MANAGEMENT CO LLC 42,538$370,0810.07%
External links

This page lists EYEPOINT PHARMACEUTICALS INC's shareholders in Q2 2024. To view EYEPOINT PHARMACEUTICALS INC's shareholder history, click here.